VEGF 165 (AA 207-371) protein (His tag)
-
- Target
- VEGF 165
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 207-371
-
Spezies
- Human
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- His tag
- Applikation
- SDS-PAGE (SDS)
- Produktmerkmale
- VEGF165, 207-371aa, Human, His tag, E.coli
- Reinheit
- > 90 % by SDS - PAGE
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5mg/ml (determined by Bradford assay)
- Buffer
- Liquid. In 20mM Tris-HCl(pH8.5), 50%glycerol, 5mM DTT, 200mM NaCl, 2mM EDTA
- Lagerung
- 4 °C
-
- Target
- VEGF 165
- Hintergrund
- Vascular endothelial growth factor (VEGF) is homodimeric, heparin-binding glycoprotein involved in both angiogenesis and vasculogenesis. VEGF is expressed as multiple alternately spliced isoforms of VEGF121, 165, 189 and 206. VEGF binds to the receptor tyrosine kinases VEGF R1 (Flt-1) and VEGF R2 (KDR/Flk-1) to activate signal transduction and regulate both physiological and pathological angiogenesis. Recombinant human VEGF165 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by conventional chromatography, after refolding of the isolated inclusion bodies in a renaturation buffer. Synonyms: Vascular endothelial growth factor A isoform d, VPF, VEGF, VEGF-A. NCBI no.: NP_001020539
- Molekulargewicht
- 21.3kDa (185aa), conformed by MALDI-TOF
-